Predicate |
Object |
contentType |
Journal Article|Comment |
endingPage |
6 |
issn |
0140-6736 |
issueIdentifier |
9683 |
pageRange |
4-6 |
publicationName |
Lancet (London, England) |
startingPage |
4 |
bibliographicCitation |
De Block CE, Van Gaal LF. GLP-1 receptor agonists for type 2 diabetes. Lancet. 2009 Jul 04;374(9683):4–6. doi: 10.1016/s0140-6736(09)60942-9. PMID: 19515414. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ad46f053c9dbd3d6c9e7a0a6b8c8b9e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c92a368d11678e3f205c7ef800864a0a |
date |
2009-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/19515414 https://doi.org/10.1016/s0140-6736%2809%2960942-9 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 https://portal.issn.org/resource/ISSN/0140-6736 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
GLP-1 receptor agonists for type 2 diabetes |
discusses |
http://id.nlm.nih.gov/mesh/M0405743 http://id.nlm.nih.gov/mesh/M0199975 http://id.nlm.nih.gov/mesh/M0160181 http://id.nlm.nih.gov/mesh/M0016238 http://id.nlm.nih.gov/mesh/M0022590 http://id.nlm.nih.gov/mesh/M0010903 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D052216Q000031 http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D014688Q000627 http://id.nlm.nih.gov/mesh/D010455Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D003924Q000453 http://id.nlm.nih.gov/mesh/D016032 http://id.nlm.nih.gov/mesh/D015337 http://id.nlm.nih.gov/mesh/D052216Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D012449 http://id.nlm.nih.gov/mesh/D000069450 http://id.nlm.nih.gov/mesh/D000077270 http://id.nlm.nih.gov/mesh/D052216Q000819 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_195d82ce0f37600d4e0197c9a0c33d49 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 |